Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Ke-Yu Song"'
Autor:
Lu-Qi Wei, Jing-Cong Tan, Yue Wang, Yi-Kun Mei, Jia-Yu Xue, Lei Tian, Ke-Yu Song, Lu Han, Ying-Chao Cui, Yi-Bing Peng, Jing-Quan Li, Ning-Ning Liu, Hui Wang
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2021)
Candida albicans (C. albicans) is an opportunistic human fungal pathogen that can cause severe infection in clinic. Its incidence and mortality rate has been increasing rapidly. Amphotericin B (AMB), the clinical golden standard antifungal agent, has
Externí odkaz:
https://doaj.org/article/d7d03163208d4e17a6a9ff156851ad76
Autor:
Ke-Yu Song1,2 soncyoo@126.com, Hui Zhao1 shuishu20022002@yahoo.com.cn, Zhen-You Jiang2 tjzhy@jnu.edu.cn, Xiao-Feng Li1 lixiaofeng.beijing@gmail.com, Yong-Qiang Deng1 dengyq1977@yahoo.com.cn, Tao Jiang1 jiang_tao@126.com, Shun-Ya Zhu1 zhu_duck@163.com, Pei-Yong Shi3 pei_yong.shi@novartis.com, Bo Zhang4 zhangbo@wh.iov.cn, Fu-Chun Zhang5 gz8hzfc@126.com, E-De Qin1 qinede@sohu.com, Cheng-Feng Qin1 qincf@bmi.ac.cn
Publikováno v:
BMC Microbiology. 2014, Vol. 14 Issue 1, p1-17. 17p.
Autor:
Jian Wang, Hui Zhao, Ke-Yu Song, Shun-Ya Zhu, Wenxin Hong, Hui-Qin Yang, Fuchun Zhang, Cheng-Feng Qin, Yong-Qiang Deng, Shuang Qiu
Publikováno v:
Scientific Reports
The kinetics of dengue virus (DENV)-specific IgA antibody in urine and the potential correlation with disease severity remain elusive. In this study, 262 serial urine samples from 78 laboratory-confirmed patients were assayed by a commercial immunogl
Autor:
Rong-Hong Hua, Cheng-Feng Qin, Xiaofeng Li, Qing Ye, Hui Zhao, Hong-Jiang Wang, Ke-Yu Song, Rui-Yuan Cao, Shihua Li, Yong-Qiang Deng, Xi Zhou, Yongxin Yu, E-De Qin
Publikováno v:
Journal of General Virology. 93:1959-1964
Japanese encephalitis (JE) remains the leading cause of viral encephalitis in the Asia-Pacific region, and the live vaccine SA14-14-2 is currently recommended by WHO and widely used in Asian countries with a good safety and efficacy profile. In this
Autor:
Ke-Yu Song, Shun-Ya Zhu, Jian Wang, Man Yu, Xue-Dong Yu, E-De Qin, Hui Zhao, Xin-Hua Tan, Xiaoping Tang, Yong-Qiang Deng, Tao Jiang, Wenxin Hong, Cheng-Feng Qin, Fuchun Zhang
Publikováno v:
Journal of Clinical Virology. 57:184-186
Identification and characterization of a linearized B-cell epitope on the pr protein of dengue virus
Autor:
Ke-Yu Song, Fuchun Zhang, Cheng-Feng Qin, E-De Qin, Qing Ye, Hong-Jiang Wang, Hui Zhao, Shihua Li, Yong-Qiang Deng, Zhen-You Jiang, Xiaofeng Li, Shun-Ya Zhu
Publikováno v:
The Journal of general virology. 94(Pt 7)
The four serotypes of dengue virus (DENV) represent one of the major mosquito-borne pathogens globally; so far no vaccine or specific antiviral is available. During virion maturation, the pr protein is cleaved from its precursor form the prM protein
Autor:
Ke-Yu Song, E-De Qin, Hui Zhao, Yu-Guang Wang, Yong-Qiang Deng, Chao-Min Zhu, Xiaofeng Li, Cheng-Feng Qin, Hong-Jiang Wang
Publikováno v:
Clinical Infectious Diseases. 57:157-158
Complete Genome Sequence of Dengue Virus Serotype 2 Cosmopolitan Genotype Strain in Guangdong, China
Autor:
Shun-Ya Zhu, Wenxin Hong, Cheng-Feng Qin, Yong-Qiang Deng, Xiaofeng Li, Hui Zhao, Ke-Yu Song, Fuchun Zhang, E-De Qin, Man Yu, Fengyu Hu, Xue-Dong Yu, Tao Jiang
Publikováno v:
Journal of Virology. 86:13808-13809
Here we report the complete genome sequence of a dengue virus serotype 2 (DENV-2) strain, GZ40, isolated in Guangdong, China, in 2010. A phylogenetic analysis classified GZ40 into the Cosmopolitan genotype, while previous Chinese DENV-2 isolates belo
Autor:
Vimalraj, Selvaraj1 (AUTHOR) vimalr50@gmail.com, Hariprabu, Krishnasamy Naidu Gopal2 (AUTHOR), Rahaman, Mostafizur3 (AUTHOR), Govindasami, Periyasami3 (AUTHOR), Perumal, Karthikeyan4 (AUTHOR), Sekaran, Saravanan5 (AUTHOR), Ganapathy, Dhanraj5 (AUTHOR)
Publikováno v:
3 Biotech. 9/1/2023, Vol. 13 Issue 10, p1-13. 13p.
Autor:
Xiaofeng Li, Hui Zhao, Shun-Ya Zhu, Fuchun Zhang, Tao Jiang, Cheng-Feng Qin, Zhen-You Jiang, Bo Zhang, E-De Qin, Pei Yong Shi, Yong-Qiang Deng, Ke-Yu Song
Publikováno v:
BMC Microbiology
Background Dengue virus (DENV) still poses a global public health threat, and no vaccine or antiviral therapy is currently available. Antibody plays distinct roles in controlling DENV infections. Neutralizing antibody is protective against DENV infec